Therefore, resisting apoptosis by inhibiting the activation of TLR4/NF-κB and JAK2/STAT3 signaling pathways may have clinical benefits for patients who suffer from sepsis induced myocardial dysfunction. This evidence concerns the gene NFKB1 and Sepsis.